East Brunswick, NJ, United States of America

Eunsung Juun

This inventor holds 1 USPTO granted patent. Top assignee: Rutgers, The State University of New Jersey. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eunsung Juun. Retrieved from https://idiyas.com/inventor/eunsung-juun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eunsung Juun: Innovator in Neurodegenerative Disease Research

Introduction

Eunsung Juun is a notable inventor based in East Brunswick, NJ (US). He has made significant contributions to the field of neurodegenerative diseases, particularly through his innovative research and patent work.

Latest Patents

Eunsung Juun holds a patent for "RNA targeting in alpha-synucleinopathies." This patent focuses on therapies and assays designed to screen for small molecules that can have therapeutic use in the control of neurodegenerative diseases such as Parkinson's and other alpha-synucleinopathies. His work in this area is crucial for advancing treatment options for these debilitating conditions.

Career Highlights

Eunsung Juun is affiliated with Rutgers, The State University of New Jersey, where he engages in groundbreaking research. His dedication to understanding and combating neurodegenerative diseases has positioned him as a key figure in this important field.

Collaborations

Eunsung collaborates with M Maral Mouradian, a fellow researcher who shares his commitment to advancing knowledge and treatment options for neurodegenerative diseases.

Conclusion

Eunsung Juun's innovative work and patent in RNA targeting for alpha-synucleinopathies highlight his significant contributions to neurodegenerative disease research. His efforts continue to pave the way for potential therapies that could improve the lives of many affected by these conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…